Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 17 Jun 24 424B5 Prospectus supplement for primary offering
- 13 Jun 24 424B5 Prospectus supplement for primary offering
- 24 Nov 23 424B5 Prospectus supplement for primary offering
- 20 Nov 23 424B5 Prospectus supplement for primary offering
- 2 Jun 22 EFFECT Notice of effectiveness
- 23 May 22 S-3/A Shelf registration (amended)
-
18 May 22 S-3 Shelf registration
GANX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3) and related Prospectus of Gain Therapeutics, Inc. for the registration of up to $100,000,000 of Common Stock, Preferred Stock, Debt Securities and Warrants, and to the incorporation by reference therein of our report dated March 25, 2022, with respect to the consolidated financial statements of Gain Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
Lugano, Switzerland
May 18, 2022